Relationship between dose of antithyroid drugs and adverse events in pediatric patients with Graves’ disease

Graves’ disease (GD) accounts for a large proportion of pediatric hyperthyroidism, and the first-line treatment is antithyroid drug (ATD) therapy. Methimazole (MMI) is effective in most patients but is associated with significant adverse events (AEs). We reviewed the medical records of GD patients (...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Clin Pediatr Endocrinol
Päätekijät: Yasuda, Kie, Miyoshi, Yoko, Tachibana, Makiko, Namba, Noriyuki, Miki, Kazunori, Nakata, Yukiko, Takano, Toru, Ozono, Keiichi
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: The Japanese Society for Pediatric Endocrinology 2017
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5295245/
https://ncbi.nlm.nih.gov/pubmed/28203042
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1297/cpe.26.1
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia